Pharmaceutical and life science multi-national Bayer said on Friday that positive synergy effects from the planned takeover of U.S. seeds maker Monsanto would be about $300 million below its previous target because it will sell more businesses than initially expected to get antitrust approval. Kate King reports.
With "My Queue" you can quickly save videos to watch later.
To add an item to your queue just click the sign next to the video.
Once you've added a video visit "My Queue" to start watching!